Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B 4
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid + resolvin E1) to leukotriene B
4
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 35, Issue 4, Pages -
Publisher
Wiley
Online
2021-03-22
DOI
10.1096/fj.202002471r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model
- (2020) Kaustubh Parashar et al. FASEB JOURNAL
- Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
- (2019) Magnus Bäck et al. Nature Reviews Cardiology
- An omega-3 fatty acid plasma index ≥4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment
- (2019) Abdulhamied Alfaddagh et al. ATHEROSCLEROSIS
- ERV1/ChemR23 Signaling Protects from Atherosclerosis by Modifying oxLDL Uptake and Phagocytosis in Macrophages
- (2018) Andres Laguna-Fernandez et al. CIRCULATION
- Resolvin E1 attenuates injury-induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration
- (2018) Guizhu Liu et al. FASEB JOURNAL
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Pro-resolving lipid mediators in vascular disease
- (2018) Michael S. Conte et al. JOURNAL OF CLINICAL INVESTIGATION
- The G-protein coupled receptor ChemR23 determines smooth muscle cell phenotypic switching to enhance high phosphate-induced vascular calcification
- (2018) Miguel Carracedo et al. CARDIOVASCULAR RESEARCH
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation
- (2018) Paul C. Norris et al. Scientific Reports
- Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia
- (2018) Gonzalo Artiach et al. Frontiers in Pharmacology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial
- (2017) Abdulhamied Alfaddagh et al. Journal of the American Heart Association
- Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
- (2016) Kanita Salic et al. ATHEROSCLEROSIS
- Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
- (2016) Joana Viola et al. CIRCULATION RESEARCH
- Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
- (2016) Tarec K. Elajami et al. FASEB JOURNAL
- An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
- (2016) Gabrielle Fredman et al. Nature Communications
- Effect of Targeting Inflammation With Salsalate
- (2016) Thomas H. Hauser et al. JAMA Cardiology
- Resolvin E1 (RvE1) Attenuates Atherosclerotic Plaque Formation in Diet and Inflammation-Induced Atherogenesis
- (2015) H. Hasturk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
- (2014) Romain A. Colas et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- The Pro-Resolving Lipid Mediator Maresin 1 (MaR1) Attenuates Inflammatory Signaling Pathways in Vascular Smooth Muscle and Endothelial Cells
- (2014) Anuran Chatterjee et al. PLoS One
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Comparison of coronary plaque subtypes in male and female patients using 320-row MDCTA
- (2012) Faisal Khosa et al. ATHEROSCLEROSIS
- Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
- (2012) Bengt Samuelsson JOURNAL OF BIOLOGICAL CHEMISTRY
- Resolvin E2 Formation and Impact in Inflammation Resolution
- (2012) S. F. Oh et al. JOURNAL OF IMMUNOLOGY
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation
- (2012) D. El Kebir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
- (2011) Gabrielle Fredman et al. BIOCHEMICAL JOURNAL
- Lipoxygenase and Leukotriene Pathways: Biochemistry, Biology, and Roles in Disease
- (2011) Jesper Z. Haeggström et al. CHEMICAL REVIEWS
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
- (2011) Sungwhan F. Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol
- (2010) Ozgur Bayturan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intravascular Ultrasound-Derived Measures of Coronary Atherosclerotic Plaque Burden and Clinical Outcome
- (2010) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets
- (2008) M. Dona et al. BLOOD
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started